Hygeia Healthcare Holdings Toekomstige groei

Future criteriumcontroles 4/6

Hygeia Healthcare Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 21.3% en 15% per jaar. De winst per aandeel zal naar verwachting groeien met 21.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13.4% zijn.

Belangrijke informatie

21.3%

Groei van de winst

21.3%

Groei van de winst per aandeel

Healthcare winstgroei	18.5%
Inkomstengroei	15.0%
Toekomstig rendement op eigen vermogen	13.4%
Dekking van analisten	Good
Laatst bijgewerkt	21 Nov 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Winst- en omzetgroeiprognoses

SZSC:6078 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	7,411	1,254	1,442	1,714	13
12/31/2025	6,224	992	1,085	1,488	16
12/31/2024	5,296	824	715	1,114	16
6/30/2024	4,699	733	59	783	N/A
3/31/2024	4,388	708	-49	783	N/A
12/31/2023	4,077	683	-158	783	N/A
9/30/2023	3,753	635	-157	764	N/A
6/30/2023	3,429	587	-156	744	N/A
3/31/2023	3,312	532	-39	715	N/A
12/31/2022	3,196	477	78	685	N/A
9/30/2022	3,053	472	-23	620	N/A
6/30/2022	2,910	468	-125	554	N/A
3/31/2022	2,613	455	-184	490	N/A
12/31/2021	2,315	441	-243	426	N/A
9/30/2021	2,008	403	-165	379	N/A
6/30/2021	1,701	365	-88	332	N/A
3/31/2021	1,551	268	-58	314	N/A
12/31/2020	1,402	170	-29	296	N/A
9/30/2020	1,302	100	-12	271	N/A
6/30/2020	1,203	29	4	246	N/A
3/31/2020	1,145	35	37	237	N/A
12/31/2019	1,086	40	69	229	N/A
12/31/2018	766	3	-131	160	N/A
12/31/2017	596	-46	N/A	67	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 6078 ( 21.3% per jaar) ligt boven de spaarquote ( 2.3% ).

Winst versus markt: De winst van 6078 ( 21.3% per jaar) zal naar verwachting sneller groeien dan de Hong Kong markt ( 11.6% per jaar).

Hoge groeiwinsten: De winst van 6078 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van 6078 ( 15% per jaar) zal naar verwachting sneller groeien dan de markt Hong Kong ( 7.8% per jaar).

Hoge groei-inkomsten: De omzet van 6078 ( 15% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 6078 zal naar verwachting over 3 jaar laag zijn ( 13.4 %).

Hygeia Healthcare Holdings Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2020 Results on Mar 29, 2021

New 90-day low: HK$45.50

Hygeia Healthcare Holdings Co., Limited Announces Change of Joint Company Secretary

New 90-day high: HK$61.15

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Insider recently bought HK$8.2m worth of stock

First half earnings released

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven